{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:19Z","timestamp":1792801459071,"version":"4.5.0"},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Radiation recall is an acute inflammatory reaction confined to previously irradiated areas that can be triggered when chemotherapy agents are administered after radiotherapy. It remains a poorly understood phenomenon, but increased awareness may aid early diagnosis and appropriate management. A diverse range of drugs used in the treatment of cancer has been associated with radiation recall. As most data come from case reports, it is not possible to determine the true incidence, but to date the antineoplastic drugs for which radiation recall reactions have been most commonly reported include the anthracycline doxorubicin, the taxanes docetaxel and paclitaxel, and the antimetabolites gemcitabine and capecitabine. Radiation recall is drug-specific for any individual patient; it is not possible to predict which patients will react to which drugs, and rechallenge does not uniformly induce a reaction. There are no identifiable characteristics of drugs that cause radiation recall, and thus, it is a possibility that must be kept in mind with use of any drug after radiotherapy, including those from new drug classes. Although it is not yet possible to design treatment regimens to eliminate the risk of radiation recall, it seems likely that risks can be minimized by prolonging the interval between completion of radiotherapy and initiation of chemotherapy.<\/jats:p>","DOI":"10.1634\/theoncologist.2009-0090","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T02:43:05Z","timestamp":1288752185000},"page":"1227-1237","source":"Crossref","is-referenced-by-count":254,"title":["Radiation Recall with Anticancer Agents"],"prefix":"10.1093","volume":"15","author":[{"suffix":"III","given":"Howard A.","family":"Burris","sequence":"first","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Hurtig","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"2021122207541079900_R1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":"Radiation recall: a well recognized but neglected phenomenon","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"2021122207541079900_R2","first-page":"209","article-title":"An ambiguous phenomenon of radiation and drugs: recall reactions","volume":"30","author":"Caloglu","year":"2007","journal-title":"Onkologie"},{"key":"2021122207541079900_R3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"key":"2021122207541079900_R4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00128071-200001020-00006","article-title":"Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management","volume":"1","author":"Yeo","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"2021122207541079900_R5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/73.2.175","article-title":"Potentiation of x-ray effects by actinomycin D","volume":"73","author":"D'Angio","year":"1959","journal-title":"Radiology"},{"key":"2021122207541079900_R6","first-page":"18","article-title":"Frequency of radiation recall dermatitis in adult cancer patients","volume":"28","author":"Kodym","year":"2005","journal-title":"Onkologie"},{"key":"2021122207541079900_R7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.02.070","article-title":"Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial","volume":"72","author":"Haffty","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207541079900_R8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00280-006-0223-8","article-title":"Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase","volume":"58","author":"Saif","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"2021122207541079900_R9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ijrobp.2006.05.073","article-title":"Frequency and characteristics of docetaxel-induced radiation recall phenomenon","volume":"66","author":"Mizumoto","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207541079900_R10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0360-3016(90)90078-X","article-title":"The \u201crecall effect\u201d in radiotherapy: is subeffective, reparable damage involved?","volume":"18","author":"Kitani","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207541079900_R11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/120347540200600603","article-title":"Histopathologic features seen with radiation recall or enhancement eruptions","volume":"6","author":"Smith","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"2021122207541079900_R12","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2002.20.13.3029","article-title":"Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine","volume":"20","author":"Ortmann","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0190-9622(83)70177-5","article-title":"Cutaneous complications of chemotherapeutic agents","volume":"9","author":"Bronner","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"2021122207541079900_R14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.1978.03280370027018","article-title":"Adriamycin-induced recall phenomenon 15 years after radiotherapy","volume":"239","author":"Burdon","year":"1978","journal-title":"JAMA"},{"key":"2021122207541079900_R15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.lungcan.2006.06.021","article-title":"Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis","volume":"54","author":"Barl\u00e9si","year":"2006","journal-title":"Lung Cancer"},{"key":"2021122207541079900_R16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/cncr.20229","article-title":"Gemcitabine-related radiation recall preferentially involves internal tissue and organs","volume":"100","author":"Friedlander","year":"2004","journal-title":"Cancer"},{"key":"2021122207541079900_R17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-81-3-407","article-title":"Letter: Adriamycin activating a recall phenomenon after radiation therapy","volume":"81","author":"Donaldson","year":"1974","journal-title":"Ann Intern Med"},{"key":"2021122207541079900_R18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.annonc.a010730","article-title":"Paclitaxel-induced radiation recall dermatitis","volume":"7","author":"Bokemeyer","year":"1996","journal-title":"Ann Oncol"},{"key":"2021122207541079900_R19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/1097-0142(197503)35:3<622::AID-CNCR2820350313>3.0.CO;2-C","article-title":"Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma","volume":"35","author":"Rosen","year":"1975","journal-title":"Cancer"},{"key":"2021122207541079900_R20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lungcan.2005.06.006","article-title":"Radiation recall dermatitis with pemetrexed","volume":"50","author":"Hureaux","year":"2005","journal-title":"Lung Cancer"},{"key":"2021122207541079900_R21","first-page":"565","article-title":"[Radiation recall pneumonitis induced by Gefitinib (Iressa): a case report]","volume":"41","author":"Miya","year":"2003","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2021122207541079900_R22","first-page":"744","article-title":"Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer","volume":"9","author":"Saif","year":"2008","journal-title":"JOP"},{"key":"2021122207541079900_R23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1440-1673.2008.01942.x","article-title":"Radiation recall dermatitis with gatifloxacin: a review of literature","volume":"52","author":"Jain","year":"2008","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2021122207541079900_R24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1634\/theoncologist.11-10-1118","article-title":"Radiation recall dermatitis with cefotetan: a case study","volume":"11","author":"Ayoola","year":"2006","journal-title":"The Oncologist"},{"key":"2021122207541079900_R25","first-page":"79","article-title":"Photo recall effect in association with cefazolin","volume":"73","author":"Garza","year":"2004","journal-title":"Cutis"},{"key":"2021122207541079900_R26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00253973","article-title":"A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections","volume":"20","author":"Jolivet","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"2021122207541079900_R27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00194596","article-title":"Skin reactions induced by trimetrexate, an analog of methotrexate","volume":"4","author":"Weiss","year":"1986","journal-title":"Invest New Drugs"},{"key":"2021122207541079900_R28","first-page":"64","article-title":"Radiation recall reaction induced by levofloxacin","volume":"7","author":"Cho","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"2021122207541079900_R29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clon.2007.02.012","article-title":"Nimesulide\u2013a new trigger of radiation recall reaction","volume":"19","author":"Ng","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122207541079900_R30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0936-6555(05)80545-X","article-title":"Radiation reaction recall following simvastatin therapy: a new observation","volume":"7","author":"Abadir","year":"1995","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122207541079900_R31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00202177","article-title":"Radiation recall in a patient with breast cancer treated for tuberculosis","volume":"48","author":"Extermann","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"2021122207541079900_R32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1075-122X.2006.00235.x","article-title":"Radiation recall dermatitis after the use of the anorexiant phentermine in a patient with breast cancer","volume":"12","author":"Ash","year":"2006","journal-title":"Breast J"},{"key":"2021122207541079900_R33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1748-717X-1-32","article-title":"Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy\u2013case report and review of literature","volume":"1","author":"Putnik","year":"2006","journal-title":"Radiat Oncol"},{"key":"2021122207541079900_R34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(96)00461-3","article-title":"Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold","volume":"33","author":"Yeo","year":"1997","journal-title":"Eur J Cancer"},{"key":"2021122207541079900_R35","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/1097-0142(19930215)71:4<1322::AID-CNCR2820710425>3.0.CO;2-Z","article-title":"Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome","volume":"71","author":"Stelzer","year":"1993","journal-title":"Cancer"},{"key":"2021122207541079900_R36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2005.06801.x","article-title":"Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug?","volume":"153","author":"Borgia","year":"2005","journal-title":"Br J Dermatol"},{"key":"2021122207541079900_R37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3747\/co.2008.201","article-title":"Radiation recall dermatitis: case report and review of the literature","volume":"15","author":"Hird","year":"2008","journal-title":"Curr Oncol"},{"key":"2021122207541079900_R38","first-page":"495","article-title":"Radiation recall phenomenon, manifested as diffuse gastritis and upper gastrointestinal bleed after capecitabine administration","volume":"4","author":"George","year":"2004","journal-title":"J Appl Res"},{"key":"2021122207541079900_R39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000372-200406000-00008","article-title":"Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy: histopathologic findings of a patient affected by multiple myeloma","volume":"26","author":"Borroni","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"2021122207541079900_R40","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archotol.1984.00800350056015","article-title":"Radiation recall supraglottitis. A hazard in head and neck chemotherapy","volume":"110","author":"Wallenborn","year":"1984","journal-title":"Arch Otolaryngol"},{"key":"2021122207541079900_R41","first-page":"470","article-title":"Radiation recall dermatitis in a patient treated with dacarbazine","volume":"13","author":"Kennedy","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122207541079900_R42","first-page":"106","article-title":"Clinical and biologic studies of actinomycin D and roentgen irradiation","volume":"87","author":"D'Angio","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"2021122207541079900_R43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00007611-197808000-00024","article-title":"Radiation-recall enteritis after actinomycin-D and adriamycin therapy","volume":"71","author":"Stein","year":"1978","journal-title":"South Med J"},{"key":"2021122207541079900_R44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.24.4.544","article-title":"The effect of actinomycin D on cancer in childhood","volume":"24","author":"Tan","year":"1959","journal-title":"Pediatrics"},{"key":"2021122207541079900_R45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0196-0709(91)90122-V","article-title":"Radiation recall supraglottitis in a child","volume":"12","author":"Wiatrak","year":"1991","journal-title":"Am J Otolaryngol"},{"key":"2021122207541079900_R46","first-page":"272","article-title":"Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence","volume":"12","author":"Camidge","year":"2000","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122207541079900_R47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hed.10352","article-title":"A case of radiation recall mucositis associated with docetaxel","volume":"26","author":"Culp","year":"2004","journal-title":"Head Neck"},{"key":"2021122207541079900_R48","first-page":"34","article-title":"Docetaxel-induced radiation recall dermatitis","volume":"135","author":"Kandemir","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"2021122207541079900_R49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2002.20.3.867","article-title":"Challenges in oncology. Case 2. Radiation recall associated with docetaxel","volume":"20","author":"Morkas","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R50","first-page":"438","article-title":"Radiation recall dermatitis from docetaxel","volume":"25","author":"Piroth","year":"2002","journal-title":"Onkologie"},{"key":"2021122207541079900_R51","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/oxfordjournals.annonc.a058742","article-title":"Docetaxel and radiation-recall severe mucositis","volume":"5","author":"Zulian","year":"1994","journal-title":"Ann Oncol"},{"key":"2021122207541079900_R52","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/1097-0142(197509)36:3<946::AID-CNCR2820360316>3.0.CO;2-5","article-title":"Radiation-adriamycin interactions: preliminary clinical observations","volume":"36","author":"Cassady","year":"1975","journal-title":"Cancer"},{"key":"2021122207541079900_R53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0360-3016(89)90086-2","article-title":"Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring","volume":"17","author":"Eifel","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207541079900_R54","first-page":"757","article-title":"Letter: Uncommon side effects of adriamycin (NSC-123127)","volume":"58","author":"Etcubanas","year":"1974","journal-title":"Cancer Chemother Rep"},{"key":"2021122207541079900_R55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5694\/j.1326-5377.1983.tb136023.x","article-title":"Recall of radiation pneumonitis after intrapleural administration of doxorubicin","volume":"1","author":"Hill","year":"1983","journal-title":"Med J Aust"},{"key":"2021122207541079900_R56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1148\/radiology.187.2.8475291","article-title":"\u201cRecall\u201d pneumonitis: adriamycin potentiation of radiation pneumonitis in two children","volume":"187","author":"Ma","year":"1993","journal-title":"Radiology"},{"key":"2021122207541079900_R57","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0360-3016(76)90091-2","article-title":"Complications of irradiation related to apparent drug potentiation by adriamycin","volume":"1","author":"Mayer","year":"1976","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207541079900_R58","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1259\/0007-1285-50-591-224","article-title":"Reactivation of radiation pneumonitis by adriamycin","volume":"50","author":"McInerney","year":"1977","journal-title":"Br J Radiol"},{"key":"2021122207541079900_R59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001813-200308000-00011","article-title":"Radiation recall dermatitis induced by pegylated liposomal doxorubicin","volume":"14","author":"Jimeno","year":"2003","journal-title":"Anticancer Drugs"},{"key":"2021122207541079900_R60","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/07357909509024929","article-title":"Radiation recall dermatitis induced by edatrexate in a patient with breast cancer","volume":"13","author":"Perez","year":"1995","journal-title":"Cancer Invest"},{"key":"2021122207541079900_R61","first-page":"224","article-title":"Radiation recall associated with VP-16\u2013213 therapy","volume":"63","author":"Fontana","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"2021122207541079900_R62","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1148\/81.6.1018","article-title":"Radiation and 5-fluorouracil: A controlled clinical study","volume":"81","author":"Essen","year":"1963","journal-title":"Radiology"},{"issue":"suppl 2","key":"2021122207541079900_R63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0560.2006.00496.x","article-title":"Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literature","volume":"33","author":"Sroa","year":"2006","journal-title":"J Cutan Pathol"},{"key":"2021122207541079900_R64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/030089160108700614","article-title":"Gemcitabine-induced radiation recall dermatitis: case report","volume":"87","author":"Bar-Sela","year":"2001","journal-title":"Tumori"},{"key":"2021122207541079900_R65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2000.18.3.695","article-title":"Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine","volume":"18","author":"Castellano","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R66","first-page":"306","article-title":"Gemcitabine-induced rectus abdominus radiation recall","volume":"7","author":"Fakih","year":"2006","journal-title":"JOP"},{"key":"2021122207541079900_R67","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0169-5002(01)00194-5","article-title":"Radiation recall reaction following gemcitabine","volume":"33","author":"Fogarty","year":"2001","journal-title":"Lung Cancer"},{"key":"2021122207541079900_R68","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1023\/A:1008353224251","article-title":"Radiation myositis: the possible role of gemcitabine","volume":"11","author":"Ganem","year":"2000","journal-title":"Ann Oncol"},{"key":"2021122207541079900_R69","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0360-3016(02)02773-6","article-title":"Gemcitabine-induced radiation recall","volume":"53","author":"Jeter","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207541079900_R70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.20379","article-title":"Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma","volume":"80","author":"Marisavljevi\u0107","year":"2005","journal-title":"Am J Hematol"},{"key":"2021122207541079900_R71","first-page":"420","article-title":"[Two cases of radiation myositis probably induced by recall phenomenon]","volume":"63","author":"Miura","year":"2003","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"key":"2021122207541079900_R72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.cad.0000181590.85476.e3","article-title":"Gemcitabine-related radiation recall in a patient with pancreatic cancer","volume":"17","author":"Saif","year":"2006","journal-title":"Anticancer Drugs"},{"key":"2021122207541079900_R73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0090-8258(03)00404-9","article-title":"Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy","volume":"91","author":"Schwartz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"2021122207541079900_R74","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1086\/520684","article-title":"Gemcitabine-related \u201cpseudocellulitis\u201d: report of 2 cases and review of the literature","volume":"45","author":"Tan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021122207541079900_R75","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1023\/A:1008365221440","article-title":"Radiation myositis","volume":"10","author":"Welsh","year":"1999","journal-title":"Ann Oncol"},{"key":"2021122207541079900_R76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00066-007-1688-z","article-title":"Radiation recall pneumonitis induced by gemcitabine","volume":"183","author":"Schwarte","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"2021122207541079900_R77","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/annonc\/mdg196","article-title":"Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors","volume":"14","author":"Castellano","year":"2003","journal-title":"Ann Oncol"},{"key":"2021122207541079900_R78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.2000.18.3.693","article-title":"Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine","volume":"18","author":"Burstein","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R79","first-page":"31","article-title":"Erythema in areas of previous irradiation in patients treated with hydroxyurea (NSC-32065)","volume":"40","author":"Sears","year":"1964","journal-title":"Cancer Chemother Rep"},{"key":"2021122207541079900_R80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/gyno.1995.1139","article-title":"Radiation recall reaction to idarubicin resulting in vaginal necrosis","volume":"57","author":"Gabel","year":"1995","journal-title":"Gynecol Oncol"},{"key":"2021122207541079900_R81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.2002.20.1.355","article-title":"Radiation recall dermatitis from high-dose interferon alfa-2b","volume":"20","author":"Thomas","year":"2002","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R82","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(87)91711-9","article-title":"Radiation recall and radiosensitization with alkylating agents","volume":"1","author":"Kellie","year":"1987","journal-title":"Lancet"},{"key":"2021122207541079900_R83","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00000421-200010000-00020","article-title":"Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease","volume":"23","author":"Kharfan Dabaja","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"2021122207541079900_R84","first-page":"55","article-title":"Radiation recall with oxaliplatin: report of a case and a review of the literature","volume":"13","author":"Chan","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122207541079900_R85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1096-911X(199609)27:3<185::AID-MPO9>3.0.CO;2-A","article-title":"Paclitaxel-induced radiation recall dermatitis","volume":"27","author":"McCarty","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"2021122207541079900_R86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.1995.13.1.305","article-title":"Radiation-recall dermatitis in a patient treated with paclitaxel","volume":"13","author":"Phillips","year":"1995","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R87","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7","article-title":"Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel","volume":"76","author":"Schweitzer","year":"1995","journal-title":"Cancer"},{"key":"2021122207541079900_R88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.1994.12.2.439","article-title":"Paclitaxel and radiation-recall dermatitis","volume":"12","author":"Shenkier","year":"1994","journal-title":"J Clin Oncol"},{"key":"2021122207541079900_R89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/030089160409000219","article-title":"Paclitaxel-carboplatin induced radiation recall colitis","volume":"90","author":"Kundak","year":"2004","journal-title":"Tumori"},{"key":"2021122207541079900_R90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/028418699432653","article-title":"Radiation recall\u2013another call with tamoxifen","volume":"38","author":"Bostr\u00f6m","year":"1999","journal-title":"Acta Oncol"},{"key":"2021122207541079900_R91","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.coc.0000189693.23157.8d","article-title":"Tamoxifen-induced radiation recall dermatitis","volume":"29","author":"Kundranda","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"2021122207541079900_R92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0140-6736(92)92460-W","article-title":"Radiation recall induced by tamoxifen","volume":"340","author":"Parry","year":"1992","journal-title":"Lancet"},{"key":"2021122207541079900_R93","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1075-122X.2004.21222.x","article-title":"Tamoxifen-induced radiation recall dermatitis","volume":"10","author":"Singer","year":"2004","journal-title":"Breast J"},{"key":"2021122207541079900_R94","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(69)91941-2","article-title":"Skin reaction to vinblastine","volume":"1","author":"Lampkin","year":"1969","journal-title":"Lancet"},{"key":"2021122207541079900_R95","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/1097-0142(19920915)70:6<1605::AID-CNCR2820700627>3.0.CO;2-S","article-title":"Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome","volume":"70","author":"Nemechek","year":"1992","journal-title":"Cancer"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2009-0090","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2009-0090","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/15\/11\/1227\/41843248\/oncolo_15_11_1227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/15\/11\/1227\/41843248\/oncolo_15_11_1227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T12:28:12Z","timestamp":1640176092000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/15\/11\/1227\/6399729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,1]]},"references-count":95,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,2]]},"published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2009-0090","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,11,1]]},"published":{"date-parts":[[2010,11,1]]}}}